anaplastic large cell lymphoma Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)
Any (2)

Phase 1/2 (2)
Unknown (1)

Interventional (2)
Observational (1)

Huiqiang Huang (1)
The First Affiliated Hospital with Nanjing Medical University (1)
The Lymphoma Academic Research Organisation (1)

No (3)

No (3)

Adult (18+) (3)

I am/have/had

I am/have/hadlymphoma

I am/have/hadmeasurable disease

I am/have/hadanaplastic large cell lymphoma

I am/have/hadneutrophil count

I am/have/hadplatelet count

I am/have/hadperipheral t-cell lymphoma

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadb-cell lymphoma

I am/have/hadct scan

I am/have/hadfollicular lymphoma

I am/have/hadpositron emission tomography

I am/have/hadserum bilirubin

I am/have/hadhigh-grade lymphoma

I am/have/hadaptt

I am/have/hadcreatinine clearance rate

I am/have/hadprothrombin time (pt)

I am/have/hadpulse oximetry

I am/have/hadfollicular lymphoma grade iiib

I am/have/hadblood transfusion

I am/have/hadebv-positive dlbcl, nos

added new label for I am/have/had

I am looking for

I am looking forrituximab

I am looking forg-csf

I am looking forlenalidomide

I am looking fororal contraceptives

I am looking forcolony stimulating factor

I am looking forcamrelizumab

I am looking forgranulocyte colony stimulating factor

I am looking foranticoagulants

I am looking forapatinib

I am looking for18f-fdg

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCL

This study will evaluate the efficacy and safety of camrelizumab in combination with apatinib in in patients with relapsed or refractory diffuse large B cell lymphoma failed from second line chemotherapy.

rituximab

granulocyte colony stimulating factor

blood transfusion

ebv-positive dlbcl, nos

difficulty breathing at rest

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Lenalidomide in Combination With CHOP in Patients With Untreated PTCL

The prognosis of PTCL (except early stage ALK+ ALCL) is dismal. Previous study showed that single agent lenalidomide showed promising therapeutic activity in patients with relapsed or refractory PTCL.

peripheral t-cell lymphoma

anaplastic large cell lymphoma

lenalidomide

0 views
19 Feb, 2024

Multi-country trial
For Seniors
For adults
Recruiting in 100s
Observational Study
For Females
Recruiting

Breast Implant-associated Anaplastic Large Cell Lymphoma (BIA-ALCL) Registry

Anaplastic large cell lymphoma associated with breast implants (BIA-ALCL) is a rare disease seen only in women with a breast implant. Because of the low incidence of this disease and the peculiar histological subtype, French authorities, in accordance with the recommendations of an expert group, recommended the implementation of a …

0 views
19 Feb, 2024